On Tuesday, June 5, 2018, BIO hosted its Food, Health and Environmental Future Day at the 2018 BIO International Convention.
Category Archives: Uncategorized
Last Chance to Save on What’s Hot in Seattle Biotech
There’s just one week left before Xconomy’s latest biotech event, “What’s Hot in Seattle Biotech.” Don’t let the clock run
DON’T MISS IT! EGVIA Workshop on EVs & their integration into the grid – State of play and challenges – 20 June 2018, BluePoint Brussels, 80 Bd. Auguste Reyers – 1030 Brussels
[Source: Research & Innovation] EGVIA (the European Green Vehicles Initiative Association) is organising #EVinthegrid2018 workshop, whose aim is to highligh
Robin Roberts Shares the Journey
When Good Morning America co-anchor Robin Roberts was diagnosed with cancer in 2007, she took her mother’s advice to “make
Portola Pharma CEO Bill Lis Plans to Retire from Company, Board
Portola Pharmaceuticals (NASDAQ: PTLA) CEO Bill Lis is retiring from the South San Francisco, CA, drug developer. Lis will also
Aravive Seeks NASDAQ Perch Via Reverse Merger With Biotech Versartis
Houston biotech Aravive Biologics is going public through a reverse merger with Versartis, a Menlo Park, CA-based company whose lead
7th International Bioeconomy Conference – 6-7 July 2018, Halle (Saale), Germany
[Source: Research & Innovation] The ScienceCampus Halle and the BioEconomy Cluster Central Germany cordially invite you to the 7th International
Director of USPTO Addressed Intellectual Property Track Opening Plenary
(left to right) Associate Counsel and Director, Intellectual Property Policy Melissa Brand, USPTO Director Andrei Iancu, Deputy General Counsel and
Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning
Eli Lilly won regulatory approval for its rheumatoid arthritis drug Friday, nearly 14 months after the FDA rejected the once-daily
Drug Price Watchdog ICER Deems Amgen Migraine Drug “Cost-Effective”
As Amgen approached an FDA decision last month for its migraine-prevention treatment, concern mounted that the drug would come at